Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
West China Hospital
Zhejiang Cancer Hospital
Shanghai Chest Hospital
Shanghai Chest Hospital
Capital Medical University
The First People's Hospital of Neijiang
Sun Yat-sen University
Persephone Biosciences
Hebei Medical University Fourth Hospital
The First Hospital of Jilin University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sykehuset i Vestfold HF
Fuzhou General Hospital
Peking Union Medical College Hospital
Shanghai University of Traditional Chinese Medicine